XFLT Faces Contentious Sub-Advisor Proxy Battle Amid Underperformance
Finance

XFLT Faces Contentious Sub-Advisor Proxy Battle Amid Underperformance

authorBy Robert Kiyosaki
DateJul 13, 2026
Read time3 min

A public dispute has erupted over the management of XAI Floating Rate & Alternative Income Trust, drawing significant investor scrutiny. This conflict centers on the proposed replacement of the current sub-advisor, Octagon, amidst concerns about the trust's recent financial performance and its trading at a notable discount to its Net Asset Value (NAV). The unfolding situation highlights broader issues within the closed-end fund landscape and the tensions that can arise between fund management, boards, and activist shareholders.

Details of the Investment Trust Conflict

Vote badge United Sates, presidential election.

Torsten Asmus/iStock via Getty Images

The XAI Floating Rate & Alternative Income Trust (XFLT) is currently embroiled in a significant proxy battle, a public dispute involving shareholder voting. This struggle revolves around whether to retain Octagon as the sub-advisor or replace them with King Street, a move advocated by XAI's board. The core of the disagreement stems from Octagon's recent underperformance and the fund's persistent trading at a discount to its Net Asset Value (NAV). The board believes King Street offers a path to greater diversification, particularly into potentially riskier European Collateralized Loan Obligations (CLOs), aiming to enhance returns. Conversely, Octagon is vigorously defending its more conservative investment approach, arguing that its strategy prioritizes stability and long-term value. To counter the board's proposal and appease shareholders, Octagon has put forward its own plan: a reduction in management fees, a simplification of the fund's operational structure, and a commitment to offer a tender for shares near NAV if it secures complete control over the fund's management. This aggressive stance positions Octagon as a more shareholder-friendly option in the eyes of some investors, directly addressing the discount to NAV. Adding another layer of complexity to this already contentious situation, activist investor Bulldog Investors has entered the fray, advocating for the complete liquidation of XFLT. Their argument centers on the fund's deep discount to NAV, suggesting that liquidation is the most effective way for shareholders to realize the full value of their investments. This intervention underscores the growing pressure on XFLT to address its valuation challenges and highlights the short-term value extraction motives often seen in activist campaigns targeting closed-end funds.

From an observer's perspective, this situation underscores the intricate dynamics within the investment fund sector. It highlights the constant tension between achieving optimal returns and maintaining investor confidence, especially when a fund is trading below its intrinsic value. The outcome of this proxy battle will not only determine the future direction of XFLT but also send a clear message to other closed-end funds regarding accountability, shareholder value, and the role of activist investors. It’s a compelling case study of how external pressures can force a reevaluation of established investment strategies and management structures, potentially paving the way for more transparent and shareholder-aligned practices across the industry. This event also serves as a reminder for investors to scrutinize not just a fund's performance, but also its governance and responsiveness to shareholder concerns, particularly when discounts to NAV become persistent.

More Articles
Finance
Debt Relief: An Overview of Options
Debt relief refers to various strategies designed to help borrowers manage and repay their outstanding financial obligations. These options, which can include debt consolidation, debt settlement, and bankruptcy, aim to reduce the burden of debt by lowering interest rates, extending repayment periods, or even forgiving a portion of the total amount. While offering much-needed respite, each method has distinct implications for a borrower's financial future and credit standing.
By Lisa JingJul 13, 2026
Finance
Second Quarter 2026 Dividend Portfolio Review
This report details the author's dividend growth investment strategy, focusing on predictable and secure income streams rather than capital appreciation. The Q2 portfolio generated C$1,976.11 and US$273.79, achieving a 1.84% year-over-year increase despite a significant dividend reduction from BCE. The author's recent acquisition of Brookfield Asset Management (BAM.A) is highlighted, noting its attractive yield and potential for income growth. The article concludes with a cautious market outlook, advocating for a long-term approach centered on high-quality, dividend-growing companies.
By Mariana MazzucatoJul 13, 2026
Finance
SpaceX's Astronomical Valuation: A Deep Dive into Discrepancy
SpaceX's valuation, estimated at nearly $2 trillion, vastly exceeds its approximate $40 billion accounting net worth and limited revenue. Only its Starlink division is currently profitable, while other ambitious projects face significant losses. The company's private valuation surged from $350 billion to an IPO valuation of $1.77 trillion in under two years, partly due to a large pre-IPO private merger. With less than 5% of its shares publicly traded, the current market price is highly speculative, further complicated by upcoming insider lock-up expiries. This analysis suggests a strong sell rating for SpaceX due to a profound mismatch between its valuation and its foundational financial realities.
By Lisa JingJul 13, 2026
Finance
Alphabet Q2 Outlook: AI-Powered Resilience Amidst Valuation Concerns
This article analyzes Alphabet's upcoming Q2 earnings, highlighting its strong position in AI through integrated hardware and software. Despite this, the current valuation raises concerns. The company's substantial cloud backlog presents both opportunity and risk, particularly regarding customer concentration. Significant capital expenditures planned for 2026 pose a challenge if monetization doesn't keep pace. The author maintains a 'Hold' rating, suggesting a cautious approach with a reduced price target of $415.
By Michele FerreroJul 13, 2026
Finance
Fulgent Genetics: Strategic Buybacks & Undervaluation Signal Potential
Fulgent Genetics (FLGT) demonstrates resilience with robust capital management and strategic share repurchases at attractive prices. Despite recent market fluctuations, the company's strong balance sheet and net assets per share significantly exceeding its current trading price suggest a compelling undervaluation, offering investors a substantial safety margin and long-term growth potential.
By David RubensteinJul 13, 2026